Long-Term Safety and Effectiveness of a Continuous Erythropoietin Receptor Activator (CERA) in Patients With Renal Anemia: A Prospective, Observational, Multicenter Study

Renal Replacement Therapy
doi 10.1186/s41100-019-0221-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search